Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian G Mcnicholl

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
European Journal of Gastroenterology & Hepatology|November 27, 2014
Response to: misleading results in the diagnosis of atrophic gastritisAdrian G McNicholl, Javier P Gisbert
The American Journal of Gastroenterology|November 8, 2017
Research to the N-Power: The Strengths of Networked Clinical Collaboration in SpainAdrian G McNicholl, Javier P Gisbert
Evidence-Based Medicine|July 9, 2016
In H. pylori- infected patients second-line treatment with sequential levofloxacin therapy was more effective than levofloxacin triple therapy but was still suboptimalAdrian G McNicholl, Javier P Gisbert
Gastroenterologia Y Hepatologia|May 23, 2019
Warnings on the safety of quinolones: Should Helicobacter pylori treatment prescriptions be modified?Adrian G McNicholl, Javier P Gisbert
Helicobacter|March 13, 2012
Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospitalJavier P Gisbert, Adrian G McNicholl
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 24, 2019
ReplyAdrian G Mcnicholl, Javier P Gisbert
Helicobacter|May 3, 2017
Optimization strategies aimed to increase the efficacy of H. pylori eradication therapiesJavier P Gisbert, Adrian G McNicholl
The American Journal of Gastroenterology|December 20, 2017
Corrigendum: Research to the N-Power: The Strengths of Networked Clinical Collaboration in SpainAdrian G McNicholl, Javier P Gisbert
Inflammatory Bowel Diseases|April 14, 2009
Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel diseaseJavier P Gisbert, Adrian G McNicholl, Fernando Gomollon
European Journal of Gastroenterology & Hepatology|November 27, 2014
Response to: accuracy of GastroPanel test in detection of atrophic gastritisAdrian G McNicholl, Julio Valle, Javier P Gisbert
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
European Journal of Gastroenterology & Hepatology|November 27, 2014
Response to: misleading results in the diagnosis of atrophic gastritisAdrian G McNicholl, Javier P Gisbert
The American Journal of Gastroenterology|November 8, 2017
Research to the N-Power: The Strengths of Networked Clinical Collaboration in SpainAdrian G McNicholl, Javier P Gisbert
Evidence-Based Medicine|July 9, 2016
In H. pylori- infected patients second-line treatment with sequential levofloxacin therapy was more effective than levofloxacin triple therapy but was still suboptimalAdrian G McNicholl, Javier P Gisbert
Gastroenterologia Y Hepatologia|May 23, 2019
Warnings on the safety of quinolones: Should Helicobacter pylori treatment prescriptions be modified?Adrian G McNicholl, Javier P Gisbert
Helicobacter|March 13, 2012
Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospitalJavier P Gisbert, Adrian G McNicholl
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 24, 2019
ReplyAdrian G Mcnicholl, Javier P Gisbert
Helicobacter|May 3, 2017
Optimization strategies aimed to increase the efficacy of H. pylori eradication therapiesJavier P Gisbert, Adrian G McNicholl
The American Journal of Gastroenterology|December 20, 2017
Corrigendum: Research to the N-Power: The Strengths of Networked Clinical Collaboration in SpainAdrian G McNicholl, Javier P Gisbert
Inflammatory Bowel Diseases|April 14, 2009
Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel diseaseJavier P Gisbert, Adrian G McNicholl, Fernando Gomollon
European Journal of Gastroenterology & Hepatology|November 27, 2014
Response to: accuracy of GastroPanel test in detection of atrophic gastritisAdrian G McNicholl, Julio Valle, Javier P Gisbert
Pageof 4